- Osteoprotegerin is present on the membrane of osteoclasts isolated from mouse long bones
-
Woo KM, Choi Y, Ko SH, Ko JS, Oh KO, Kim KK
- KMID: 755206
- Exp Mol Med.
- 2002 Nov;34(5):347-352.
Osteoprotegerin (OPG), a member of the tumor necrosis factor receptor superfamily, is known to inhibit osteoclastogenesis by acting as a soluble decoy receptor for the receptor activator of NF-kB ligand... -
- CITED
-
- Close
- SHARE
-
- Close
- Platinum nanoparticles reduce ovariectomy-induced bone loss by decreasing osteoclastogenesis
-
Kim WK, Kim JC, Park HJ, Sul OJ, Lee MH, Kim JS, Choi HS
- KMID: 1397447
- Exp Mol Med.
- 2012 Jul;44(7):432-439.
Platinum nanoparticles (PtNP) exhibit remarkable antioxidant activity. There is growing evidence concerning a positive relationship between oxidative stress and bone loss, suggesting that PtNP could protect against bone loss by... -
- CITED
-
- Close
- SHARE
-
- Close
- Inhibitory action of bisphosphonates on bone resorption does not involve the regulation of RANKL and OPG expression
-
Kim YH, Kim GS, Baek JH
- KMID: 1081464
- Exp Mol Med.
- 2002 May;34(2):145-151.
The mechanism of inhibitory action of bisphosphonates on bone resorption is not fully elucidated. Osteoclast formation and activity are regulated by osteoblast-derived factors such as the osteoclast differentiating factor, receptor... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of alpha MSH Analogues on Rat Bones
-
Lim SK, Li SZ, Rhee Y, Chung SS, Jin YJ, Yook JI
- KMID: 1122009
- Yonsei Med J.
- 2002 Aug;43(4):500-510.
- doi: 10.3349/ymj.2002.43.4.500
Melanocortin is the downstream mediator of leptin signaling and absence of leptin signaling in ob/ob and db/db mice revealed the enhancement of bone formation through the central regulation. While alpha-melanocyte-stimulating... -
- CITED
-
- Close
- SHARE
-
- Close
